{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:11:00Z","timestamp":1784128260948,"version":"3.55.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"\n Importance<\/jats:title>\n Cardiovascular disease (CVD) is the leading cause of mortality in patients with psoriasis, yet structured CVD prevention is not routinely embedded in dermatology care.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the effectiveness of a text-messaging intervention in improving patient activation and cardiovascular risk factors among patients with psoriasis.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This single-center, parallel-group randomized clinical trial took place at a tertiary hospital dermatology clinic in Australia from February 2024 to February 2025. Adults with dermatologist-confirmed psoriasis were randomized 1:1 during outpatient dermatology visits between April and July 2024. Data were analyzed from February to April 2025.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n A 6-month text-messaging intervention (Tobacco, Exercise, and Diet Messages for Psoriasis [TEXTME PSO]), comprising 4 text messages per week, compared with standard care.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was score on the 13-item Patient Activation Measure. Secondary outcomes included Mediterranean Diet Score, physical activity, cardiometabolic measures, psoriasis-CVD knowledge, medication adherence, Psoriasis Area and Severity Index, Dermatology Life Quality Index, and user feedback. Analysis of covariance was used to adjust for baseline values under an intention-to-treat framework with multiple imputation.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 111 participants (mean [SD] age, 51.8 [13.2] years; 71 [65.1%] male), the intervention showed a statistically significant improved patient activation at 6 months compared with usual care (adjusted mean difference, 10.8 points; 95% CI, 7.0-14.6 points;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Statistically significant improvements were also observed in Mediterranean diet adherence (adjusted mean difference, 1.7; 95% CI, 1.0-2.4;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), medication adherence (adjusted mean difference, 1.6; 95% CI, 0.8-2.5;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and psoriasis-CVD knowledge (adjusted mean difference, 6.6; 95% CI, 4.7-8.4;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Minutes per week of physical activity increased (adjusted mean difference, 127.9; 95% CI, 21.9-234.0;\n P<\/jats:italic>\n \u2009=\u2009.02), and body mass index, calculated as weight in kilograms divided by height in meters squared, decreased (adjusted mean difference, \u22121.0; 95% CI, \u22121.4 to \u22120.7;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). No statistically significant between-group differences were observed for lipid parameters, hemoglobin A\n 1c<\/jats:sub>\n , smoking behavior, dermatology-specific quality of life, or psoriasis severity.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, a text-messaging intervention improved patient activation and cardiovascular risk behaviors in adults with psoriasis. While biomarker changes were modest or not statistically significant, findings support digital tools as an adjunct to cardiovascular risk in dermatology care.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ANZCTR Identifier:\n ACTRN12624000498594<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamadermatol.2026.1070","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:00:32Z","timestamp":1778684432000},"page":"675","source":"Crossref","is-referenced-by-count":0,"title":["Text Messaging for Cardiovascular Risk Prevention in Psoriasis"],"prefix":"10.1001","volume":"162","author":[{"given":"Annika","family":"Smith","sequence":"first","affiliation":[{"name":"Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia"},{"name":"Westmead Applied Research Centre (WARC), Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishana","family":"Dixit","sequence":"additional","affiliation":[{"name":"Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Zhang","sequence":"additional","affiliation":[{"name":"Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Marschner","sequence":"additional","affiliation":[{"name":"Westmead Applied Research Centre (WARC), Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haeri","family":"Min","sequence":"additional","affiliation":[{"name":"Westmead Applied Research Centre (WARC), Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara K.","family":"Chow","sequence":"additional","affiliation":[{"name":"Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Westmead Applied Research Centre (WARC), Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Cardiology, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"21","key":"doi260014r1","doi-asserted-by":"publisher","first-page":"11574","DOI":"10.3390\/ijms222111574","article-title":"Current concepts of psoriasis immunopathogenesis.","volume":"22","author":"Vicic","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"doi260014r2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.","volume":"68","author":"Armstrong","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi260014r3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.","volume":"36","author":"Wu","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi260014r4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.868277","article-title":"Psoriasis and cardiovascular diseases: an immune-mediated cross talk?","volume":"13","author":"Orlando","year":"2022","journal-title":"Front Immunol"},{"key":"doi260014r5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fimmu.2018.01234","article-title":"Potential immunological links between psoriasis and cardiovascular disease.","volume":"9","author":"Sajja","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"doi260014r6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/ddg.15071","article-title":"Cardiovascular comorbidity in psoriasis\u2014psoriatic inflammation is more than just skin deep.","volume":"21","author":"Kommoss","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"doi260014r7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.det.2014.09.004","article-title":"Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.","volume":"33","author":"Ryan","year":"2015","journal-title":"Dermatol Clin"},{"issue":"5","key":"doi260014r8","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","article-title":"Psoriasis and cardiovascular risk: a comprehensive review.","volume":"37","author":"Masson","year":"2020","journal-title":"Adv Ther"},{"issue":"14","key":"doi260014r9","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis.","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"doi260014r10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology.","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi260014r11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jaad.2012.05.016","article-title":"The impact of psoriasis on 10-year Framingham risk.","volume":"67","author":"Mehta","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi260014r12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s13555-024-01098-z","article-title":"Does systemic anti-psoriatic treatment impact the risk of cardiovascular disease? a review over cardiovascular imaging studies.","volume":"14","author":"Kaiser","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"doi260014r13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"doi260014r14","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1161\/CIR.0000000000000677","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"doi260014r16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/hex.13225","article-title":"Determinants of patient activation and its association with cardiovascular disease risk in chronic kidney disease: a cross-sectional study.","volume":"24","author":"Wilkinson","year":"2021","journal-title":"Health Expect"},{"issue":"5","key":"doi260014r17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s11606-011-1931-2","article-title":"Why does patient activation matter? an examination of the relationships between patient activation and health-related outcomes.","volume":"27","author":"Greene","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"4","key":"doi260014r18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1475-6773.2006.00669.x","article-title":"Do increases in patient activation result in improved self-management behaviors?","volume":"42","author":"Hibbard","year":"2007","journal-title":"Health Serv Res"},{"issue":"1","key":"doi260014r19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1359105320947790","article-title":"Patient activation in adults with chronic conditions: a systematic review.","volume":"26","author":"Newland","year":"2021","journal-title":"J Health Psychol"},{"key":"doi260014r20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-publhealth-031914-122855","article-title":"Mobile text messaging for health: a systematic review of reviews.","volume":"36","author":"Hall","year":"2015","journal-title":"Annu Rev Public Health"},{"issue":"12","key":"doi260014r21","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1001\/jama.2015.10945","article-title":"Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial.","volume":"314","author":"Chow","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"doi260014r22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4082\/kjfm.20.0053","article-title":"Psoriasis and cardiovascular disease: a narrative review.","volume":"42","author":"Martinez-Moreno","year":"2021","journal-title":"Korean J Fam Med"},{"issue":"9","key":"doi260014r23","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15685","article-title":"The role of lifestyle and nutrition in psoriasis: current status of knowledge and interventions.","volume":"35","author":"Musumeci","year":"2022","journal-title":"Dermatol Ther"},{"key":"doi260014r24","first-page":"189","article-title":"Psoriasis and exercise: a review.","volume":"12","author":"Yeroushalmi","year":"2022","journal-title":"Psoriasis (Auckl)"},{"issue":"9","key":"doi260014r25","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jamadermatol.2018.2127","article-title":"Association between Mediterranean anti-inflammatory dietary profile and severity of psoriasis: results from the NutriNet-Sant\u00e9 cohort.","volume":"154","author":"Phan","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"doi260014r26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCRESAHA.118.313348","article-title":"The Mediterranean diet and cardiovascular health.","volume":"124","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2019","journal-title":"Circ Res"},{"issue":"2","key":"doi260014r27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ad.2021.11.011","article-title":"RF\u2014role of the Mediterranean diet in the treatment of psoriasis.","volume":"114","author":"Berna-Rico","year":"2023","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"doi260014r28","doi-asserted-by":"publisher","DOI":"10.2196\/35876","article-title":"The use of Dietary Approaches to Stop Hypertension (DASH) mobile apps for supporting a healthy diet and controlling hypertension in adults: systematic review.","volume":"6","author":"Alnooh","year":"2022","journal-title":"JMIR Cardio"},{"key":"doi260014r29","doi-asserted-by":"publisher","DOI":"10.2196\/46439","article-title":"Benefits and harms of digital health interventions promoting physical activity in people with chronic conditions: systematic review and meta-analysis.","volume":"25","author":"Zangger","year":"2023","journal-title":"J Med Internet Res"},{"issue":"6","key":"doi260014r30","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.473","article-title":"Using wearable technology to objectively investigate physical behaviour and determine health outcomes of a physical activity intervention in patients with psoriasis.","volume":"4","author":"Sheppard","year":"2024","journal-title":"Skin Health Dis"},{"issue":"14","key":"doi260014r31","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jacc.2018.08.2141","article-title":"Promoting physical activity and exercise: JACC health promotion series.","volume":"72","author":"Fletcher","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"doi260014r32","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.2015.10858","article-title":"Exercise is medicine: at any dose?","volume":"314","author":"Eijsvogels","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"doi260014r34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s13555-024-01327-5","article-title":"Biologic therapy and cardiometabolic risk in psoriasis: a retrospective review.","volume":"15","author":"Smith","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"doi260014r35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.0954-6820.1986.tb08932.x","article-title":"Effects of exercise on glucose tolerance and insulin resistance: brief review and some preliminary results.","volume":"711","author":"Holloszy","year":"1986","journal-title":"Acta Med Scand Suppl"},{"issue":"10","key":"doi260014r36","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1249\/MSS.0000000000001667","article-title":"Glucose tolerance is linked to postprandial fuel use independent of exercise dose.","volume":"50","author":"Gilbertson","year":"2018","journal-title":"Med Sci Sports Exerc"},{"issue":"19","key":"doi260014r37","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1001\/jamainternmed.2013.7783","article-title":"The influence of hyperglycemia on the therapeutic effect of exercise on glycemic control in patients with type 2 diabetes mellitus.","volume":"173","author":"Solomon","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"1","key":"doi260014r38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2133.2012.11205.x","article-title":"Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.","volume":"168","author":"Balato","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi260014r39","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1111\/ajd.14436","article-title":"Improving cardiovascular outcomes in the psoriasis cohort: psoriasis and cardiovascular disease-clinician knowledge, practice and perceptions.","volume":"66","author":"Smith","year":"2025","journal-title":"Australas J Dermatol"},{"issue":"4","key":"doi260014r40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/24755303221101848","article-title":"Specialist and patient perspectives on strategies to improve cardiovascular disease prevention among persons living with psoriatic disease.","volume":"7","author":"Gustafson","year":"2022","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"doi260014r15","volume-title":"Patient Activation Measure\u201313 Item Version (PAM-13)","author":"Hibbard","year":"2005"},{"key":"doi260014r33","volume-title":"Endotext","author":"Feingold","year":"2024"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2848886\/jamadermatology_smith_2026_oi_260014_1783528903.60987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:00:53Z","timestamp":1784127653000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2848886"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2026.1070","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}